STRANDDX
LIVE

Serial Number

99287105

Owner

Linus Biotechnology Inc.

Attorney

Michael R Rizzo

Filing Date

Jul 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

STRANDDX Trademark

Serial Number: 99287105

STRANDDX is a trademark filed by Linus Biotechnology Inc. on July 16, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Linus Biotechnology Inc. (5 trademarks)

83 Woodlawn Avenue
New Rochelle, NY 10804

Entity Type: 03

Trademark Details

Filing Date

July 16, 2025

Registration Date

Not Registered

Goods & Services

Research laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer

Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples

Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes

Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes

Filing History

ASSIGNED TO EXAMINER
Apr 13, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 4, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 16, 2025 MAFR
NEW APPLICATION ENTERED
Jul 16, 2025 NWAP